Literature DB >> 35303123

[Socioeconomic risks for people with cancer-possible consequences and assistance].

Ulf Seifart1.   

Abstract

Due to therapeutic progress, about 60% of all cancer patients currently survive their disease more than five years. These long-term survivors can be described as cured, but not as healthy. In particular, reduced performance and an associated reduction in working hours, loss of job, or an early retirement can lead to socioeconomic consequences. On average, tumor patients in Germany lose up to 26% of their income, although this does not seem to be necessarily linked to the stage of the disease and thus the corresponding prognosis. Due to objective and subjective financial burdens, a so-called "financial toxicity" can develop, which can have a significant impact on the quality of life and possibly also on the prognosis of the disease.In this article, the socioeconomic risks associated with cancer are presented as well as possible patient assistance and offers. This presentation intends to illustrate how financial toxicity in cancer can be prevented or alleviated. As far as scientific findings are available, they will be described and discussed.Finally, the special situation of young adults with cancer is explained, for whom many of the above-mentioned support measures are not or only partially possible.
© 2022. Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature.

Entities:  

Keywords:  Poverty from cancer; Quality of life; Return to work; Social support; Young adults with cancer

Mesh:

Year:  2022        PMID: 35303123     DOI: 10.1007/s00103-022-03510-5

Source DB:  PubMed          Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz        ISSN: 1436-9990            Impact factor:   1.513


  6 in total

Review 1.  Return to Work of Cancer Survivors.

Authors:  Ulf Seifart; Jan Schmielau
Journal:  Oncol Res Treat       Date:  2017-11-29       Impact factor: 2.825

2.  Predictors of employment among cancer survivors after medical rehabilitation--a prospective study.

Authors:  Anja Mehnert; Uwe Koch
Journal:  Scand J Work Environ Health       Date:  2012-03-15       Impact factor: 5.024

3.  The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in Italy.

Authors:  F Perrone; C Jommi; M Di Maio; A Gimigliano; C Gridelli; S Pignata; F Ciardiello; F Nuzzo; A de Matteis; L Del Mastro; J Bryce; G Daniele; A Morabito; M C Piccirillo; G Rocco; L Guizzaro; C Gallo
Journal:  Ann Oncol       Date:  2016-10-26       Impact factor: 32.976

4.  Career and Financial Situation of Patients Diagnosed with Soft Tissue Sarcomas.

Authors:  Nele Laros; Kiangenda Trésor Sungu-Winkler; Susanne Gutermuth; Markus Wartenberg; Peter Hohenberger; Ulf Seifart; Bernd Kasper
Journal:  Oncol Res Treat       Date:  2020-09-16       Impact factor: 2.825

5.  Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia.

Authors:  Stacie B Dusetzina; Aaron N Winn; Gregory A Abel; Haiden A Huskamp; Nancy L Keating
Journal:  J Clin Oncol       Date:  2013-12-23       Impact factor: 44.544

6.  Why Do Our Cancer Patients Sleep So Badly? Sleep Disorders in Cancer Patients: A Frequent Symptom with Multiple Causes.

Authors:  Herwig Strik; Werner Cassel; Michael Teepker; Thomas Schulte; Jorge Riera-Knorrenschild; Ulrich Koehler; Ulf Seifart
Journal:  Oncol Res Treat       Date:  2021-07-20       Impact factor: 2.825

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.